Abstract
BACKGROUND/OBJECTIVES: Precision medicine is not just hype. Instead, it represents a high bar for developing more effective, safer, and better-tolerated therapies in medicine, without exception in psychiatry, including bipolar disorder (BD). A burgeoning body of narrative reviews and perspective papers has already appraised the boundaries of precision medicine in BD. METHODS: This brief perspective follows a narrative, critical approach focusing explicitly on the antipsychotic management of BD using precision approaches. RESULTS: While most controversies align with those previously appraised in BD's overall precision medicine approach, specific insights are provided herein. CONCLUSIONS: Beyond other implications and the strengthened call for valid diagnostic coding systems, the implementation of shared decision-making tools and pharmacogenomics studies focusing on persons with BD are particularly warranted.